Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Propanc Biopharma Inc PPCB

Healthcare Biotechnology
Propanc Biopharma, Inc. is an Australia-based clinical biopharmaceutical company. The Company is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from... see more

Recent & Breaking News (OTCPK:PPCB)

Public Company Executives to Present Online to Investors on December 1

PR Newswire November 23, 2016

Propanc Health Group Corporation to Webcast, Live, at VirtualInvestorConferences.com December 1

PR Newswire November 22, 2016

OTC Company Executives to Present Online to Investors on September 8

Canada NewsWire September 7, 2016

Propanc Files Application for Orphan Medicinal Product Designation in the EU for Pancreatic Cancer

MarketWire Canada September 7, 2016

Propanc Health Group Corporation to Webcast, Live, at VirtualInvestorConferences.com September 8

Canada NewsWire September 1, 2016

Propanc Identifies Future Opportunities for PRP as Pharma Executives Look for New Breakthroughs

PR Newswire June 15, 2016

Propanc Provides Shareholder Update on PRP Development Activities

PR Newswire June 13, 2016

Propanc Engages Two Advisory Firms to Identify Strategic Partnering Opportunities

PR Newswire May 31, 2016

Propanc Completes Successful Roadshow in New York City

PR Newswire May 11, 2016

Propanc Conducts Successful Scientific Advice Meeting with the MHRA

PR Newswire May 2, 2016

Propanc Announces Launch of New Corporate Website

PR Newswire April 29, 2016

Penny Stocks to Watch: Four Top Small Cap Stocks on Tuesday April 26

Accesswire April 26, 2016

Propanc Files Two More Patents Citing New Compositions of Proenzymes for Cancer Treatment

PR Newswire April 19, 2016

SeeThruEquity Issues Update on Propanc Health Group Corp (OTCQB: PPCH), Highlighting Recent Financing

Accesswire April 14, 2016

Propanc Announces Institutional Investor Roadshow, April 28th to May 4th

PR Newswire March 29, 2016

Propanc Receives $1.2 Million to Fast Track Animal Safety Studies, GMP Manufacturing and Preclinical Development for Lead Product, PRP

PR Newswire March 21, 2016

Technical Data Influencing the Market -- Analyst Notes on Propanc Health Group, Rocky Mountain High Brands, Schneider Electric and Assa Abloy

Accesswire March 16, 2016

Top Penny Stocks to Watch, Friday 3/11/2016

Accesswire March 11, 2016

Analyzing the Price Movement - Analyst Research on Propanc Health Group, Medical Marijuana, Progressive Care and Kirkland Lake Gold

Accesswire March 8, 2016

Propanc Health Group Corp. (OTCQB: PPCH) Developing New Cancer Treatments for Patients Suffering from Pancreatic and Colorectal Cancers

Accesswire March 7, 2016